Proof of mechanism and target engagement of glutamatergic drugs for the treatment of schizophrenia: RCTs of pomaglumetad and TS-134 on ketamine-induced psychotic symptoms and pharmacoBOLD in healthy volunteers
| Image |  |
|---|---|
| Description | scientific article published on 13 May 2020 |
| Author/s |
author: Stephen R Marder Jeffrey Lieberman Melanie Wall Michael Foster Green John Krystal Junghee Lee |
| Publication date | May 13, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |